Efficacy and safety of low dose oral prednisolone as compared to pulse intravenous methylprednisolone in managing moderate severe Graves’ orbitopathy: A randomized controlled trial

BACKGROUND: High dose oral prednisolone (100 mg/day) in Graves’ orbitopathy (GO) is limited by lesser response, and greater side-effects compared to intravenous (iv) methylprednisolone. Low dose oral prednisolone has not been evaluated in GO. This study aimed to evaluate the safety and efficacy of l...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Indian J Endocrinol Metab
Hlavní autoři: Roy, Ajitesh, Dutta, Deep, Ghosh, Sujoy, Mukhopadhyay, Pradip, Mukhopadhyay, Satinath, Chowdhury, Subhankar
Médium: Artigo
Jazyk:Inglês
Vydáno: Medknow Publications & Media Pvt Ltd 2015
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4366772/
https://ncbi.nlm.nih.gov/pubmed/25932389
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2230-8210.152770
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky